Multiple aspects of the phenotype of mammary epithelial cells transformed by expression of activated M-Ras depend on an autocrine mechanism mediated by hepatocyte growth factor/scatter factor

Molecular Cancer Research

Volumn 2, Issue 4, 2004, Pages 242-255

  Zhang, Kai Xin ^a   Ward, Katherine R ^a   Schrader, John W ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; BATIMASTAT; GELATINASE A; GELATINASE B; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUTRALIZING ANTIBODY; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN M RAS; RAS PROTEIN; SCATTER FACTOR; UNCLASSIFIED DRUG; UROKINASE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST EPITHELIUM; CELL ANCHORAGE; CELL COUNT; CELL STRAIN; CELL STRAIN SCP 2; CELL TRANSFORMATION; CONTROLLED STUDY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; ANTIBODIES; AUTOCRINE COMMUNICATION; BLOOD PROTEINS; CELL COUNT; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CONTACT INHIBITION; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; ENZYME ACTIVATION; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; MAMMARY GLANDS, ANIMAL; MICE; MONOMERIC GTP-BINDING PROTEINS; MUTATION; NEOPLASM INVASIVENESS; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT;

ANIMALIA; MURINAE;

EID: 3543096382     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Ehrhardt GR, Korherr C, Wieler JS, Knaus M, Schrader JW. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth. Oncogene 2001;20:188-97.
2. Kimmelman AC, Osada M, Chan AM. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells. Oncogene 2000; 19:2014-22.
3. Louahed J, Grasso L, De Smet C, et al. Interleukin-9-induced expression of M-Ras/R-Ras3 oncogene in T-helper clones. Blood 1999;94:1701-10.
4. Matsumoto K, Asano T, Endo T. Novel small GTPase M-Ras participates in reorganization of actin cytoskeleton. Oncogene 1997;15:2409-17.
5. Quilliam LA, Castro AF, Rogers-Graham KS, Martin CB, Der CJ, Bi C. M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1 and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J Biol Chem 1999;274:23850-7.
6. Ehrhardt A, Ehrhardt GR, Guo X, Schrader JW. Ras and relatives-job sharing and networking keep an old family together. Exp Hematol 2002;30: 1089-106.
7. McCormick F. Signaling networks that cause cancer. Trends Cell Biol 1999; 9:M53-6.
8. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989;49:4682-9.
9. Bos JL, Franke B, M'Rabet L, Reedquist K, Zwartkruis F. In search of a function for the Ras-like GTPase Rap1. FEBS Lett 1997;410:59-62.
10. Graham SM, Oldham SM, Martin CB, et al. TC21 and Ras share indistinguishable transforming and differentiating activities. Oncogene 1999; 18:2107-16.
11. Ehrhardt GR, Leslie KB, Lee F, Wieler JS, Schrader JW. M-Ras, a widely expressed 29-kD homologue of p21 Ras: expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line. Blood 1999;94:2433-44.
12. Kimmelman A, Tolkacheva T, Lorenzi MV, Osada M, Chan AM. Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution. Oncogene 1997; 15:2675-85.
13. Hamad NM, Elconin JH, Karnoub AE, et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 2002;16:2045-57.
14. Gao X, Satoh T, Liao Y, et al. Identification and characterization of RA-GEF-2, a Rap guanine nucleotide exchange factor that serves as a downstream target of M-Ras. J Biol Chem 2001;276:42219-25.
15. Rebhun JF, Castro AF, Quilliam LA. Identification of guanine nucleotide exchange factors (GEFs) for the Rap1 GTPase. Regulation of MR-GEF by M-Ras-GTP interaction. J Biol Chem 2000;275:34901-8.
16. Downward J. Ras signaling and apoptosis. Curr Opin Genet Dev 1998;8: 49-54.
17. Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 2001;21:2203-12.
18. Ward KR, Zhang KX, Somairi AM, Roskelley CD, Schrader JW. Oncogene 2004;23:1187-96.
19. Perou CM, Jeffrey SS, van de Rijn M, et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 1999;96:9212-7.
20. Boon K, Osorio EC, Greenhut SF, et al. An anatomy of normal and malignant gene expression. Proc Natl Acad Sci USA 2002;99:11287-92.
21. Rahimi N, Tremblay E, McAdam L, Park M, Schwall R, Elliott B. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth & Differ 1996;7:263-70.
22. Garbett EA, Reed MW, Stephenson TJ, Brown NJ. Proteolysis in human breast cancer. Mol Pathol 2000;53:99-106.
23. Iwata H, Kobayashi S, Iwase H, Okada Y. The expression of MMPs and TIMPs in human breast cancer tissues and importance of their balance in cancer invasion and metastasis. Nippon Rinsho 1995;53:1805-10.
24. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C. Scatter factor/ hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 1993;123:223-35.
25. Brinkmann V, Foroutan H, Sachs M, Weidner KM, Birchmeier W. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol 1995;131:1573-86.
26. Janda E, Lehmann K, Killisch I, et al. Ras and TGF[β] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002;156:299-313.
27. Nagy J, Curry GW, Hillan KJ, et al. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg Oncol 1996;5:15-21.
28. Jeffers M, Rong S, Vande Woude GF. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signaling in human cells concomitant with induction of the urokinase proteolysis network. Mol Cell Biol 1996;16:1115-25.
29. Edakuni G, Sasatomi E, Satoh T, Tokunaga O, Miyazaki K. Expression of the hepatocyte growth factor/c-Met pathway is increased at the cancer front in breast carcinoma. Pathol Int 2001;51:172-8.
30. Dunsmore SE, Rubin JS, Kovacs SO, Chedid M, Parks WC, Welgus HG. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J Biol Chem 1996;271:24576-82.
31. Kermorgant S, Aparicio T, Dessirier V, Lewin MJ, Lehy T. Hepatocyte growth factor induces colonic cancer cell invasiveness via enhanced motility and protease overproduction. Evidence for PI3 kinase and PKC involvement. Carcinogenesis 2001;22:1035-42.
32. Tanimura S, Nomura K, Ozaki K, Tsujimoto M, Kondo T, Kohno M. Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility. J Biol Chem 2002;277:28256-64.
33. Zeigler ME, Chi Y, Schmidt T, Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J Cell Physiol 1999;180:271-84.
34. Ried S, Jager C, Jeffers M, et al. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor. J Biol Chem 1999;274:16377-86.
35. Sengupta S, Gherardi E, Sellers LA, Wood JM, Sasisekharan R, Fan TP. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor. Arterioscler Thromb Vasc Biol 2003;23: 69-75.
36. Fan S, Ma YX, Wang JA, et al. The cytokine hepatocyte growth factor/scatter factor inhibits apoptosis and enhances DNA repair by a common mechanism involving signaling through phosphatidyl inositol 3′ kinase. Oncogene 2000; 19:2212-23.
37. Hung W, Elliott B. Co-operative effect of c-Src tyrosine kinase and Stat3 in activation of hepatocyte growth factor expression in mammary carcinoma cells. J Biol Chem 2001;276:12395-403.
38. Desprez PY, Lin CQ, Thomasset N, Sympson, CJ, Bissell MJ, Campisi J. A novel pathway for mammary epithelial cell invasion induced by the helix-loop-helix protein Id-1. Mol Cell Biol 1998;18:4577-88.
39. Amundadottir LT, Merlino G, Dickson RB. Transgenic mouse models of breast cancer. Breast Cancer Res Treat 1996;39:119-35.
40. Desprez PY, Hara E, Bissell MJ, Campisi J. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1. Mol Cell Biol 1995;15:3398-404.
41. Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 1992;89:9064-8.
42. Li Y, Bhargava MM, Joseph A, Jin L, Rosen EM, Goldberg ID. Effect of hepatocyte growth factor/scatter factor and other growth factors on motility and morphology of non-tumorigenic and tumor cells. In Vitro Cell Dev Biol Anim 1994;30A:105-10.
43. Seftor RE. Electrophoretic analysis of proteins associated with tumor cell invasion. Electrophoresis 1994;15:454-62.